| Literature DB >> 35335375 |
Katarzyna Jakimiuk1, Jakub W Strawa1, Sebastian Granica2, Marcello Locatelli3, Angela Tartaglia3, Michał Tomczyk1.
Abstract
A new 5,7-dihydroxy-3'-methoxy-4'-acetoxyflavone-8-C-β-d-arabinopyranoside-2″-O-(4‴-acetoxy)-glucoside (6) and three known flavone C-glycosides-5,7,3',4'-tetrahydroxyflavone-6-C-xyloside-8-C-β-d-glucoside (lucenin-1) (7), 5,7,3'-trihydroxyflavone-6-C-glucoside-8-C-β-d-glucoside (vicenin-2) (8), and 5,7,4'-trihydroxy-3'-methoxyflavone-6-C-β-d-glucopyranoside-8-C-α-arabinopyranoside (chrysoeriol-6-C-β-d-glucopyranoside-8-C-α-arabinopyranoside) (9)-were isolated from aerial parts of Scleranthus perennis L. (Caryophyllaceae). Their structures were determined through the use of comprehensive spectroscopic and spectrometric methods, and a method for the quantification of the major constituents of S. perennis and S. annuus L. was developed. Furthermore, the anti-collagenase and antioxidant activities of all isolated compounds obtained from extracts and fractions from both Scleranthus species were evaluated. The highest percentage of collagenase inhibition (at 400 µg/mL) was distinguished for methanolic extracts (22.06%, 32.04%) and ethyl acetate fractions (16.59%, 14.40%) from S. annuus and S. perennis. Compounds 6-9 displayed moderate inhibitory activity, with IC50 values ranging from 39.59-73.86 µM.Entities:
Keywords: Scleranthus annuus; Scleranthus perennis; antioxidant; c-flavones; collagenase; enzyme inhibition
Mesh:
Substances:
Year: 2022 PMID: 35335375 PMCID: PMC8951040 DOI: 10.3390/molecules27062015
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Chemical structures of compounds 6–9.
Figure 2Important 1H–1H COSY and HMBC correlations for compound 6.
Qualitative analysis of SP1–SP6 and SA1–SA6 by liquid chromatography photodiode array detection mass spectrometry (LC-PDA-MSn).
| Analyte | Rt | UV Spectra | -ESI–MS ( | Fragmentation A | Predicted Compounds |
|---|---|---|---|---|---|
| I | 7.6 | 268, 302 | 459 | 293 | Apiopaeonoside ( |
| II | 7.9 | 260, 300sh, 325 | 385 | 191 | Quinic acid derivative |
| III | 11.35 | 270, 345 | 579 | 459, 399, | Flavone |
| IV | 12.8 | 257, 273, 348 | 579 | Lucenin-1 ( | |
| V | 17.51 | 270, 348 | 579 |
| Flavone 6,8-di- |
| VI | 18.01 | 254, 270, 348 | 593 |
| vicenin-2 ( |
| VII | 19.45 | 254, 270, 348 | 593 | Flavone 6,8-di- | |
| VIII | 21.86 | 255, 273, 348 | 593 | Chrysoeriol-6- | |
| IX | 33.18 | 275, 348 | 593 | Flavone 6,8-di- | |
| X | 35.23 | 270, 348 | 593 | Flavone 6,8-di- | |
| XI | 40.13 | 265, 348 | 563 | Flavone | |
| XII | 41.64 | 270, 345 | 579 | 489, 399, | Flavone |
| XIII | 42.4 | 255, 270, 347 | 635 | Flavone | |
| XIV | 44.8 | 255, 270, 348 | 621 | 579, 531, 399, | scleranthoside A ( |
| XV | 46.2 | 270, 345 | 677 | Flavone- | |
| XVI | 48.6 | 255, 270, 348 | 593 | scleranthoside B ( | |
| XVII | 56.69 | 255, 270, 349 | 677 | 413 | Flavone- |
| XVIII | 58.47 | 254, 268, 348 | 677 | 545, 455, | scleranthoside C ( |
| XIX | 64.11 | 268, 348 | 635 | 413 | Luteolin-8- |
| XX | 66.86 | 268, 348 | 635 | 413 | Luteolin-8- |
| XXI | 74.55 | 253, 270, 348 | 677 | Luteolin-8- | |
| XXII | 75.98 | 252, 268, 348 | 677 | 413 | scleranthoside D ( |
| XXIII | 90.87 | 270, 348 | 677 | 413 | Luteolin-8- |
| XXIV | 98.34 | 252, 268, 348 | 677 | scleranthoside D ( |
A bold, most abundant ion; hex, hexoside; pent, pentoside; I compounds 1–9 isolated from S. perennis.
Phytochemical analysis of total phenolic (TPC), phenolic acid (TPAC), and tannin contents (TTC) of SA1–SA6 and SP1–SP6.
| Sample | TPC | TPAC | TTC |
|---|---|---|---|
|
| 103.16 ± 0.80 | 7.20 ± 0.19 | 8.64 ± 0.15 |
|
| 103.08 ± 1.84 | 6.66 ± 0.18 | 11.01 ± 0.98 |
|
| 95.72 ± 1.69 | 6.12 ± 0.17 | 7.35 ± 0.18 |
|
| 106.04 ± 2.71 | 8.91 ± 0.27 | 8.07 ± 1.35 |
|
| 217.20 ± 1.60 | 11.34 ± 0.63 | 6.3 ± 0.90 |
|
| 159.44 ± 1.40 | 9.19 ± 0.54 | 8.22 ± 0.45 |
All data are represented as the mean with standard deviation from triplicate measurement; A expressed as pyrogallol equivalents (Peq); B expressed as caffeic acid equivalents (CAeq).
Quantification of selected metabolites (1–9) in extracts and fractions (SA1–SA6, SP1–SP6).
| Compound A | SA1 | SP1 | SA2 | SP2 | SA3 | SP3 | SA4 | SP4 | SA5 | SP5 | SA6 | SP6 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| BLQ | 0.12 ± 0.01 | 0.20 ± 0.01 | 0.23 ± 0.01 | ND | 0.11 ± 0.01 | BLQ | 0.17 ± 0.01 | 1.61 ± 0.01 | 1.61 ± 0.01 | 0.57 ± 0.03 | 0.52 ± 0.04 |
|
| 0.56 ± 0.01 | 1.66 ± 0.01 | 1.10 ± 0.07 | 2.20 ± 0.11 | 0.73 ± 0.01 | 2.09 ± 0.07 | 0.12 ± 0.01 | 1.26 ± 0.01 | 5.08 ± 0.02 | 12.85 ± 0.01 | 1.28 ± 0.01 | 5.22 ± 0.01 |
|
| 0.36 ± 0.01 | 4.90 ± 0.05 | 0.94 ± 0.03 | 6.29 ± 0.13 | 0.62 ± 0.01 | 6.38 ± 0.06 | 0.34 ± 0.01 | 5.55 ± 0.01 | 2.03 ± 0.2 | 59.10 ± 0.08 | 0.32 ± 0.01 | 1.05 ± 0.02 |
|
| BLQ | 1.98 ± 0.02 | BLQ | 0.71 ± 0.01 | ND | 2.07 ± 0.01 | 0.24 ± 0.06 | 3.81 ± 0.01 | 8.14 ± 0.14 | 18.97 ± 0.08 | ND | ND |
|
| 1.05 ± 0.01 | 1.06 ± 0.02 | 0.58 ± 0.01 | 0.91 ± 0.04 | 0.68 ± 0.01 | 0.73 ± 0.01 | 0.36 ± 0.01 | 0.93 ± 0.01 | 3.79 ± 0.01 | 6.93 ± 0.04 | BLQ | ND |
|
| 0.72 ± 0.02 | 0.11 ± 0.01 | 0.56 ± 0.04 | BLQ | 0.46 ± 0.03 | 0.10 ± 0.01 | ND | ND | 0.25 ± 0.01 | ND | 3.40 ± 0.01 | 1.44 ± 0.02 |
|
| 0.19 ± 0.01 | 0.16 ± 0.01 | 0.16 ± 0.01 | 0.15 ± 0.01 | 0.13 ± 0.01 | 0.15 ± 0.01 | ND | ND | 0.28 ± 0.11 | ND | 0.90 ± 0.01 | 1.37 ± 0.01 |
|
| 0.11 ± 0.01 | ND | BLQ | ND | BLQ | ND | ND | ND | 0.33 ± 0.12 | ND | 0.45 ± 0.05 | 0.50 ± 0.01 |
| Total | 13.74 ± 0.1 | 17.4 ± 0.27 | 13.49 ± 0.18 | 18.69 ± 0.21 | 11.27 ± 0.05 | 18.97 ± 0.32 | 4.62 ± 0.16 | 17.6 ± 0.26 | 71.8 ± 3.1 | 136.13 ± 0.39 | 20.52 ± 0.78 | 21.03 ± 0.36 |
|
| ND | 1.37 ± 0.04 | ND | 2.11 ± 0.04 | ND | 1.08 ± 0.02 | ND | ND | 0.98 ± 0.12 | 0.83 ± 0.11 | 0.74 ± 0.04 | 7.74 ± 0.13 |
A Content presented as mg/g of extract calculated in 3 equivalents for 1–4, 6–9; all data are represented as the mean with standard deviation from triplicate measurement; BLQ, below the limit of quantification; ND, not detected.
Antioxidant activities of SP1–SP6, SA1–SA6, and compounds 1–9.
| Sample | DPPH A | ABTS A | FRAP B | CUPRAC A |
|---|---|---|---|---|
|
| 193.16 ± 2.56 | 215.74 ± 2.46 | 2.02 ± 0.49 | 7.14 ± 1.32 |
|
| 186.41 ± 1.93 | 253.65 ± 3.72 | 3.17 ± 0.66 | 5.38 ± 0.76 |
|
| 118.49 ± 1.46 | 425.69 ± 2.33 | 3.30 ± 0.15 | 13.29 ± 0.76 |
|
| 157.09 ± 0.97 | 175.99 ± 2.03 | 1.96 ± 0.53 | 1.86 ± 0.32 |
|
| 354.32 ± 2.90 | 577. 82 ± 3.51 | 6.74 ± 0.98 | 67.80 ± 1.32 |
|
| 386.59 ± 2.19 | 459.29 ± 1.40 | 7.50 ± 0.32 | 45.82 ± 1.01 |
|
| 405.15 ± 3.12 | 765.16 ± 2.83 | 39.25 ± 1.42 | 581.32 ± 3.61 |
|
| 198.43 ± 2.40 | 188.57 ± 1.86 | 5.68 ± 0.68 | 114.56 ± 2.04 |
|
| 7.11 ± 0.59 | 198.57 ± 2.46 | 2.37 ± 0.36 | 67.30 ± 1.30 |
|
| 9.64 ± 0.82 | 302.05 ± 2.42 | 2.65 ± 0.47 | 44.22 ± 1.35 |
|
| 61.96 ± 1.90 | 444.23 ± 0.47 | 2.75 ± 0.11 | 48.46 ± 1.75 |
|
| 6.69 ± 0.97 | 169.27 ± 1.68 | 3.05 ± 0.25 | 18.57 ± 0.76 |
|
| 409.16 ± 2.03 | 796.61 ± 1.23 | 45.30 ± 2.49 | 116.16 ± 0.76 |
|
| 176.71 ± 0.97 | 369.24 ± 3.05 | 5.16 ± 0.96 | 27.15 ± 1.32 |
|
| 407.05 ± 1.83 | 586.69 ± 2.91 | 9.07 ± 0.45 | 18.20 ± 0.76 |
All data are represented as the mean with standard deviation from triplicate measurement; A expressed as Trolox equivalents (Teq); B expressed as Fe2+ equivalents.
Anti-collagenase activity of compounds 6–9 and their respective IC50 values.
| Compound | IC50 (µM) |
|---|---|
|
| 39.59 ± 1.21 |
|
| 73.86 ± 1.03 |
|
| 53.37 ± 0.88 |
|
| 71.06 ± 0.97 |
| EGCG A | 34.82 ± 0.53 |
All data are represented as the mean of IC50 values with standard deviation from triplicate measurements; A epigallocatechin gallate, positive control.
Percentage of anti-collagenase activity of SP1–SP6 and SA1–SA6 (at 400 µg/mL).
| Sample | Percentage of Inhibition (%) A |
|---|---|
|
| 32.04 ± 0.45 |
|
| 10.90 ± 0.11 |
|
| 12.12 ± 0.41 |
|
| 19.42 ± 0.22 |
|
| 16.59 ± 0.19 |
|
| 7.11 ± 0.17 |
A All data are represented as the mean of percentage values with standard deviation from triplicate measurements.
Regression equation, linear range, limit of detection (LOD), limit of quantification (LOQ), accuracy, and precision obtained during optimization of the LC-PDA method.
| Compound | Regression Equation A | R2 | Linear Range (µg/mL) | LOD | LOQ | Accuracy | Precision |
|---|---|---|---|---|---|---|---|
|
| y = 2374x + 63.119 | 0.9999 | 0.05–10 | 0.03 | 0.09 | 98.43 ± 3.70 | 1.3/1.95 |
|
| y = 4563.2x − 28.098 | 0.9999 | 0.01–5 | 0.003 | 0.01 | 101.28 ± 3.95 | 0.97/1.23 |
A The value for y corresponds to the peak area and x to the concentration, respectively; B expressed as RSD measured intra- and inter-day, respectively.